Advertisement Novo Nordisk shares plunged nearly 10% on Thursday, November 21, 2025. The dramatic drop followed news that its experimental Alzheimer’s drug failed a major clinical trial. This setback marks another low point for the Danish pharmaceutical giant in a challenging year.The company confirmed the Phase 3 trial results in a public statement. According to … Continue reading Novo Nordisk Stock Plummets as Alzheimer’s Drug Fails Key Trial